Meduloc
PrivateLast Round
Series B
Aug 6, 2026
Total Funding Raised
$8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Meduloc operates in Healthcare & Life Sciences and is based in Del Mar, California. Its latest recorded funding round was a Series B round in August 2026.
Meduloc is a medical device company that develops minimally invasive intramedullary fixation systems for small and long bone fractures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Meduloc Comparables
Compare Meduloc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fusion Orthopedics | 83% | |
| Extremity Medical, LLC | 83% | |
| RMR Ortho, Inc. | 82% |
For institutional investors. Book with your work email.
Meduloc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 6, 2026 | ||||
| Series A | Feb 6, 2026 | ||||
| Seed | Feb 21, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Meduloc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GenHenn Capital | Series B |
| Benjamin Franklin Technology Partners | Series B |
| Life Sciences Greenhouse Investments | Series B |
| Broad Street Angels | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 6, 2026
$4M round with participation from Benjamin Franklin Technology Partners and Broad Street Angels.
- Feb 6, 2026
$2.16M round raised
For institutional investors. Book with your work email.
Meduloc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Meduloc's valuation, stock price, and market status.
Is Meduloc a public or private company?
Meduloc is a private company.
What is the current stock price of Meduloc?
Meduloc is a private company, so its shares have no public market price. Caplight tracks Meduloc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Meduloc worth (valuation)?
Valuation information for Meduloc is not publicly available.
Can I buy Meduloc stock?
Meduloc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Meduloc's last funding round?
Meduloc's most recent funding round was Series B on August 6, 2026.
Who are the main investors in Meduloc?
Key investors in Meduloc include GenHenn Capital.
Will Meduloc IPO soon?
No public IPO plans have been announced for Meduloc.
How can I track Meduloc secondary market activity?
Caplight tracks bids, offers, and trades in Meduloc's shares on secondary markets.